Abstract: Objective?To study the clinical efficacy of sufentanil in target controlled infusion (TCI) analgesia after laparoscopic radicalhysterectomy for cervical cancer.Methods?From February 2015 to December 2016,a total of 64 patients with cervical cancer who performed laparoscopic radicalhysterectomy in ourhospital were selected anddivided randomly into observation group and control group with 32 cases for each,and carried out TCI analgesia and patient-controlled analgesia respectively for analgesia after the operation.The blood gas analysis before and 1-,4- and 8h after analgesia,and the analgesic effects and sedative effects before and 1-,6-,12,24,48h after analgesia were compared between the two groups.The adverse reactions of the two groups were also compared.Results?The pH,PaO2?and PaCO2?indexes were normal in both groups before and 1-,4h and 8h after analgesia,and there was no statisticaldifference between the two groups (P>0.05).The VAS scores were similar without statisticaldifference in both two groups before analgesia(P>0.05).But the VAS score was obviously lower in the observation group than that in the control group atdifferent time point after the analgesia,and there was statisticaldifferences between two groups (P<0.05).There was no statisticaldifference in the Ramsay score before analgesia and 48h after analgesia between two groups (P>0.05)，while significant statisticaldifference existed at other time points between two groups (P<0.05).The adverse reaction rate was 3.13% of the observation group and 18.75% of the control group,and there was statisticaldifference between two groups(χ2=4.0100，P=0.0452).Conclusion?The analgesic effect and sedative effect of sufentanil can achieve reliable effect in TCI analgesia after laparoscopic radical resection for cervical cancer,and it is worthy of being popularization.
李鹏1，周伟1，袁永群2. 舒芬太尼用于腹腔镜宫颈癌根治术后靶控输注镇痛的临床效果[J]. 中国现代手术学杂志, 2018, 22(1): 77-80.
LI Peng. Clinical Effect of Sufentanil in TCI Analgesia after Laparoscopic Radical Hysteyectomy for Cervical Cancer. Chinese Journal of Modern Operative Surgery, 2018, 22(1): 77-80.
|[1] 陈丹丹，阳志军，李力.ⅠB～ⅡB期宫颈癌治疗相关研究进展[J].国际妇产科学杂志，2015，42(1)：96-100.|[2] Ghaemmaghami F,Saleh-Gargari S,Sahebdel B,et al.Risk factors and clinical aspects of recurrent invasive cervical carcinoma[J].J Obstet Gynaecol India,2012,62(6):674-678.doi: 10.1007/s13224-012-0227-8.|[3] Kim HS,Kim K,Ryoo SB,et al.Conventional versus nerve-sparing radical surgery for cervical cancer: a meta-analysis[J].J Gynecol Oncol,2015,26(2):100-110.doi: 10.3802/jgo.2015.26.2.100.|[4] 徐嘉莹，桑诺尔，任丽英，等.不同舒芬太尼配置浓度对术后患者静脉自控镇痛效果和不良反应的影响[J].中国医学科学院学报，39(3)：406-410.|[5] 杨琦琳，柴静，王坚伟.靶控输注舒芬太尼或瑞芬太尼用于妇科腹腔镜手术麻醉的临床研究[J].重庆医科大学学报，2012，37(3)：267-269.|[6] Bahar M,McAuley DM,Dundee JW.An alternative visual analogue scale[J].Anaesthesia,1982,37(3):342.|[7] Mondello E,Siliotti R,Noto G,et al.Bispectral Index in ICU: correlation with Ramsay Score on assessment of sedation level[J].J Clin Monit Comput,2002,17(5):271-277.|[8] 吴琼，赵艳，郭向阳.舒芬太尼及其靶控输注的药代动力学研究进展[J].中国微创外科杂志,2013，13(10)：941-943.|[9] 王依慰，陈春龙，支亦博，等.瑞芬太尼与舒芬太尼全身麻醉后对患者苏醒质量影响的Meta分析[J].医学研究生学报，2016，29(2)：170-177.|[10] 罗国占，陈明湖，曾伟，等.不同剂量舒芬太尼复合曲马多用于烧伤患儿术后镇痛的比较[J].临床麻醉学杂志，2014，14(8):758-761.|[11] 刘维，赵艳，吴琼，等.腔镜手术患者舒芬太尼靶控输注的药动学研究[J].中国微创外科杂志，2016，16(12)：1131-1134，1142.|[12] 李代红.腹腔镜下宫颈癌根治术61例临床效果观察[J].中国伤残医学，2014，22(3)：91-92.|[13] 白延斌，王航辉，陈彬，等.纳美芬预防舒芬太尼术后镇痛恶心呕吐作用临床研究[J].陕西医学杂志,2015,44(7):871-872.|[14] 万友，王汉兵，杨承祥，等．TcI舒芬太尼和瑞芬太尼复合麻醉 用于腹腔镜下结直肠癌根治术病人麻醉麻醉恢复质量的比较[J]．中华麻醉学杂志，2012，32(4)：447-450．|[15] 徐林.靶控输注丙泊酚和不同剂量的舒芬太尼用于宫颈癌根治手术的研究[J].江西医药,2015,3(50):56.|[16] Jeleazcov C,Saari TI,Ihmsen H,et al.Changes in total and unbound concentrations of sufentanilduring targetcontrolled infusion for cardiac surgery with cardiopulmonary bypass[J].Br J Anaesth,2012,109(5):698-706.doi: 10.1093/bja/aes253.
2018, Vol. 22 
